Recruiting Bladder Cancer Studies in Murrieta
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)...
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer....
About Bladder Cancer Clinical Trials in Murrieta
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Murrieta, CA. These studies are seeking a combined 779 participants. Research is being sponsored by Ferring Pharmaceuticals, CG Oncology, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Murrieta — FAQ
Are there bladder cancer clinical trials in Murrieta?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Murrieta, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Murrieta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Murrieta research site will contact you about next steps.
Are clinical trials in Murrieta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Murrieta studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Murrieta are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov